Update – 07/02/2022
February 7, 2022
As of the latest update by the Greek authorities, the total number of confirmed Covid-19 diagnosed cases in Greece 2,047,849. 95 new deaths were reported raising the total number to 24,094. The number of patients treated in intensive care units is currently 551. 10,985 new cases were announced yesterday in Greece. 2,772 of the new cases were found in the Attica region and 1,433 new cases in the Thessaloniki region.
People who received the last of two doses of a coronavirus vaccine seven months ago or longer and those who received the single-dose Johnson & Johnson shot more than three months ago, are no longer considered fully vaccinated in Greece.
Starting Monday, their vaccination certificates will be considered expired after Greek health authorities set stricter limits with regards to the primary vaccination series, and they will have to get a booster shot to be regarded as fully covered once more.
It is not clear if EU certificates – which are valid for nine months after completion of vaccination – will be considered valid to enter museums, shops, restaurants and other indoor venues once in Greece if more than seven months have elapsed from the last dose.
Greece on Sunday reported 10,985 new cases of coronavirus and 95 more deaths. According to the same data, 551 patients were on ventilators.
Greece is bolstering its defenses against Covid-19 and helping ease the pressure on the national health system with the introduction of home deliveries of antiviral drugs to high-risk patients, which began last Tuesday. These antivirals are prescribed in the early stages of the disease and their purpose is to prevent a serious deterioration.
Patients have shown a strong interest and already in the first three days of the program’s implementation, 384 applications were submitted for the procurement of the drugs. Most of these applications (359) were approved and the drugs were delivered by courier to the patients.
However, experts have been quick to stress that the new drug options can in no way replace the role of vaccines.
“The availability of new treatments should not be a cause for complacency about vaccinations,” Deputy Health Minister Mina Gaga said in comments to Kathimerini.
“The vaccine remains our main weapon in the fight against the pandemic,” she said, adding that “new antiviral drugs, if given in the first few days after diagnosis, can help older people with serious health problems who are at risk for serious illness.”
Greece currently has 5,700 doses of Molnupiravir antivirals by Merck (MSD) available and will receive an additional 25,000 doses as soon as the drug is approved by European regulators, which is expected within a month.
Eligible patients are those with a positive rapid or molecular test, while the application must be submitted within three days from the time of diagnosis.
It is administered mainly to people over the age of 65, those with a body mass index over 35, transplant recipients, hemodialysis patients, cancer patients and people with chronic kidney or liver disease, diabetes, hypertension, respiratory disease or heart failure, etc.
Health Minister Thanos Plevris rebutted on Friday media reports according to which the government has limited the role of Professor Sotiris Tsiodras, epidemiologist and scientific advisor on the pandemic, in the regular government briefings.
“The regular briefing of the political leadership of the Ministry of Health is continued by Professor Sotiris Tsiodras, who, of course, has full access to all epidemiological data in the country. Any report alleging that access to the data has been blocked is completely inaccurate,” he said in a statement.
Plevris added that the latest briefing on the pandemic by Tsiodras took place earlier on Friday.
In more detail, the 10,985 new cases detected per Regional Unit: